Scholarlink

<p>Hepatocellular carcinoma (HCC) remains a major cause of morbidity and mortality among patients with chronic hepatitis B (CHB). Existing HCC risk scores are largely based on baseline variables and do not account for longitudinal changes over time. We aimed to develop and validate a longitudinal predictive model for HCC using time-dependent Cox regression. We retrospectively analyzed 4,431 patients with CHB followed between 2009 and 2022. After excluding patients with viral co-infections, early HCC, or incomplete data, 2,245 patients were included. The cohort was randomly divided into a training set (n = 1,685) and a test set (n = 562). Time-updated demographic, clinical, and laboratory variables were incorporated into the model. During follow-up, 121 patients developed HCC. Independent predictors of HCC included age, sex, platelet count, cirrhosis, serum albumin, and α-fetoprotein (AFP). These variables were incorporated into the final model (PSU HCC score): (0.023 × age) − (0.627 × female sex) − (0.847 × albumin) − (0.005 × platelet count [× 10<sup>3</sup>]) + (1.052 × log₁₀AFP) + (1.817 × cirrhosis). In the test cohort, the PSU HCC score demonstrated excellent discrimination (C-index 0.909; 95% CI, 0.870–0.947) and good calibration, outperforming ALBI, aMAP, REACH-B, CU-HCC, PAGE-B, and mPAGE-B scores. Risk stratification revealed significantly higher cumulative HCC incidence among patients in the high-risk group. Sensitivity analyses evaluating longer-term prediction at 3 and 5&#xa0;years confirmed stable and robust performance. The PSU HCC score is a longitudinal prediction model that integrates dynamic clinical and laboratory parameters and provides superior HCC risk prediction in patients with CHB. This approach may support individualized, risk-based HCC surveillance strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development of a longitudinal predictive model for hepatocellular carcinoma occurrence in patients with chronic hepatitis B

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Apichat Kaewdech,
  • Chanavee Toh,
  • Pimsiri Sripongpun,
  • Naichaya Chamroonkul,
  • Pisit Tangkijvanich,
  • Teerha Piratvisuth,
  • Suthat Liangpunsakul,
  • Paramee Thongsuksai,
  • Thammasin Ingviya

摘要

Hepatocellular carcinoma (HCC) remains a major cause of morbidity and mortality among patients with chronic hepatitis B (CHB). Existing HCC risk scores are largely based on baseline variables and do not account for longitudinal changes over time. We aimed to develop and validate a longitudinal predictive model for HCC using time-dependent Cox regression. We retrospectively analyzed 4,431 patients with CHB followed between 2009 and 2022. After excluding patients with viral co-infections, early HCC, or incomplete data, 2,245 patients were included. The cohort was randomly divided into a training set (n = 1,685) and a test set (n = 562). Time-updated demographic, clinical, and laboratory variables were incorporated into the model. During follow-up, 121 patients developed HCC. Independent predictors of HCC included age, sex, platelet count, cirrhosis, serum albumin, and α-fetoprotein (AFP). These variables were incorporated into the final model (PSU HCC score): (0.023 × age) − (0.627 × female sex) − (0.847 × albumin) − (0.005 × platelet count [× 103]) + (1.052 × log₁₀AFP) + (1.817 × cirrhosis). In the test cohort, the PSU HCC score demonstrated excellent discrimination (C-index 0.909; 95% CI, 0.870–0.947) and good calibration, outperforming ALBI, aMAP, REACH-B, CU-HCC, PAGE-B, and mPAGE-B scores. Risk stratification revealed significantly higher cumulative HCC incidence among patients in the high-risk group. Sensitivity analyses evaluating longer-term prediction at 3 and 5 years confirmed stable and robust performance. The PSU HCC score is a longitudinal prediction model that integrates dynamic clinical and laboratory parameters and provides superior HCC risk prediction in patients with CHB. This approach may support individualized, risk-based HCC surveillance strategies.